XML 33 R37.htm IDEA: XBRL DOCUMENT
v3.20.1

Share-Based Compensation (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding | A summary of the stock option activity under the Company’s plans for the nine months ended March 31, 2020 is as follows:
|  | Number of shares |  |  | Weighted average exercise price |
Options outstanding at June 30, 2019 |  |  | 5.5 |  |  | $ | 24.45 |
Options granted |  |  | — |  |  | $ | — |
Less: |  |  |  |  |  |  |  |
Options exercised |  |  | (0.4 | ) |  | $ | 22.93 |
Options canceled or expired |  |  | (0.3 | ) |  | $ | 26.78 |
Options outstanding at March 31, 2020 |  |  | 4.8 |  |  | $ | 24.43 |
Options exercisable at March 31, 2020 |  |  | 4.8 |  |  | $ | 24.43 |
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Restricted Stock Units Outstanding | A summary of the RSU activity under the Company’s plans for the nine months ended March 31, 2020 is as follows:
|  | Number of shares |  |  | Weighted average grant date fair value |
RSUs outstanding at June 30, 2019 |  |  | 2.4 |  |  | $ | 37.70 |
RSUs granted |  |  | 1.4 |  |  | $ | 28.50 |
Less: |  |  |  |  |  |  |  |
RSUs vested |  |  | (0.9 | ) |  | $ | 35.66 |
RSUs canceled |  |  | (0.3 | ) |  | $ | 39.31 |
RSUs outstanding at March 31, 2020 |  |  | 2.6 |  |  | $ | 33.21 |
Schedule of Share-Based Compensation Recognized in Consolidated Statements of Operations | Share-based compensation expense recognized and included in the condensed consolidated statements of income and comprehensive income was allocated as follows:
|  | Three months ended |  |  | Nine months ended |
|  | March 31, |  |  | March 31, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Cost of molecular diagnostic testing |  | $ | 0.3 |  |  | $ | 0.3 |  |  | $ | 0.9 |  |  | $ | 0.6 |
Cost of pharmaceutical and clinical services |  |  | 0.1 |  |  |  | 0.1 |  |  |  | 0.2 |  |  |  | 0.2 |
Research and development expense |  |  | 1.2 |  |  |  | 1.7 |  |  |  | 3.8 |  |  |  | 3.9 |
Selling, general, and administrative expense |  |  | 5.9 |  |  |  | 7.4 |  |  |  | 18.4 |  |  |  | 20.0 |
Total share-based compensation expense |  | $ | 7.5 |  |  | $ | 9.5 |  |  | $ | 23.3 |  |  | $ | 24.7 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.F) -URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration